Related Experiment Video
Updated: Mar 24, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Pharmacologic and nonpharmacologic approaches to the prevention and management of delirium
Ann C Schwartz1, Travis J Fisher2, Heather N Greenspan1
1Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.
Abstract:
Delirium is a syndrome of neuropsychiatric signs and symptoms that can accompany virtually any serious medical condition. Delirium is characterized by a disturbance of attention and awareness, as well as variety of other aspects of cognition that develops over a short period of time in response to another medical condition. It is an independent risk factor for increased morbidity and mortality and is associated with increased lengths of stay and costs of care. Despite this, it frequently goes unrecognized, and debate continues about the best prevention and treatment strategies. This article will review the current best practices for the prevention and treatment of delirium and how collaborative care can aid in improving outcomes and minimizing adverse events for patients suffering from delirium.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Alzheimer's Disease: Treatment
Psychosis and Antipsychotic Drugs: Overview
Drug Dosing: Geriatric Patients
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

